Clinical Outcome, Hormonal Status, Gonadotrope Axis, and Testicular Function in 219 Adult Men Born With Classic 21-Hydroxylase Deficiency. A French National Survey
The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
CONTEXT: Outcomes of congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency (21OHD) have been widely studied in children and women, but less so in men. OBJECTIVE: The objective was to analyze data from a network of metropolitan French teaching hospitals on the clinical outcome of classic 21OHD in a large sample of congenital adrenal hyperplasia/21OHD-genotyped adult men, and particularly the impact of 21OHD on the gonadotrope axis, testicular function, and fertility. METHODS: From April 2011 to June 2014, tertiary endocrinology departments provided data for 219 men with 21OHD (ages, 18-70 y; 73.6% salt wasters, 26.4% simple virilizers). Testicular sonography was performed in 164 men, and sperm analysis was performed in 71 men. RESULTS: Mean final height was 7.8 cm lower than in a reference population. Obesity was more common, and mean blood pressure was lower than in the reference population. None of the patients were diabetic, and lipid status was generally normal. Blood electrolyte status was normal in the vast majority of men, despite markedly elevated ACTH and renin levels. Serum progesterone, 17-hydroxyprogesterone, and androstenedione levels were above normal in the vast majority of cases. Hormonal profiling variously showed a normal gonadotrope-testicular axis, gonadotropin deficiency, or primary testicular insufficiency. Testicular sonography revealed testicular adrenal rest tumors (TARTs) in 34% of 164 men. Serum inhibin B and FSH levels were significantly lower and higher, respectively, in patients with TARTs. Severe oligospermia or azoospermia was found in 42% of patients and was significantly more prevalent in men with TARTs (70%) than in men with normal testes (3.6%; P < .0001). Among men living with female partners, TARTs were significantly more prevalent in those who had not fathered children. CONCLUSION: We report the spectrum of testicular/gonadotrope axis impairment in the largest cohort of 21OHD men studied to date. Our results suggest that French men with 21OHD managed in specialized centers frequently have impaired exocrine testicular function but that its reproductive implications are often overlooked.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The majority of patients (79.4%) and treating healthcare professionals (71.8%) were satisfied with the surgical outcomes.”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [624]
In the citing paper
“A common and important complication in individuals with male reproductive organs and CAH is the development of TART96,97.”
From Management challenges and therapeutic advances in congenital adrenal hyperplasia (2022) · cites this paper as [96]
In the citing paper
“The presence of TARTs is a predictor of infertility (226, 248, 253).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [253]
Citations
Cites
World Health Organization reference values for human semen characteristics*‡
Cooper, T. G., Noonan, E., von Eckardstein, S., Auger, J., Baker, H. W. G., Behre, H. M., Haugen, T. B., Kruger, T., Wang, C., Mbizvo, M. T., et al. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmp048 · Cited by 2,827 · cited 1×
“Sperm status was classified, as recommended by the World Health Organization (WHO) in 2010 (27), as normal ( 15 10(6) sperm/mm(3)), oligospermic ( 15 10(6) sperm/mm(3)), severely oligospermic ( 5 10(6) sperm/mm(3)), or azoospermic (Table 2).”
MethodSpeiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468 · cited 3×
“Congenitaladrenalhyperplasiadueto21OHD does not therefore seem to affect men’s intimate relationships, whereas sexuality is severely affected in women with this disease, who are markedly less likely to live with a partner (1, 3, 6, 7, 9).”
BackgroundSpeiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Global Sodium Consumption and Death from Cardiovascular Causes
Mozaffarian, D., Fahimi, S., Singh, G. M., Micha, R., Khatibzadeh, S., Engell, R. E., Lim, S., Danaei, G., Ezzati, M., & Powles, J. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1304127 · Cited by 1,218 · cited 2×
“To test this hypothesis, it would be interesting to measure natriuresis (28).”
BackgroundCongenital adrenal hyperplasia.
Merke, D. P., & Bornstein, S. R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66736-0 · Cited by 628
Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients
Arlt, W., Willis, D. S., Wild, S. H., Krone, N., Doherty, E. J., Hahner, S., Han, T. S., Carroll, P. V., Conway, G. S., Rees, D. A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0917 · Cited by 506 · cited 12×
“These results are similar to those reported by Arlt et al (12) and Finkielstain et al (13) who studied 65 and 21 men with 21OHD, respectively, in the United Kingdom and the United States.”
BackgroundResultInfluentialNew, M. I., Abraham, M., Gonzalez, B., Dumic, M., Razzaghy-Azar, M., Chitayat, D., Sun, L., Zaidi, M., Wilson, R. C., & Yuen, T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300057110 · Cited by 365 · cited 1×
“21OHD is caused by loss-of-function mutations in CYP21A2, the gene encoding the adrenal enzyme 21-hydroxylase (2).”
BackgroundClinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia
Finkielstain, G. P., Kim, M. S., Sinaii, N., Nishitani, M., Van Ryzin, C., Hill, S. C., Reynolds, J. C., Hanna, R. M., & Merke, D. P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2102 · Cited by 313 · cited 2×
“Arlt et al (12) reported similar findings in the United Kingdom, whereas Finkielstain et al (13) found that hypertension was more frequent in adults with classic 21OHD than in the healthy US population.”
ResultStikkelbroeck, N. M. M. L., Otten, B. J., Pasic, A., Jager, G. J., Sweep, C. G. J. F., Noordam, K., & Hermus, A. R. M. M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8090 · Cited by 305
Newborn screening for congenital adrenal hyperplasia
Therrell, B. L. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(08)70017-3 · Cited by 221
Cited by
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Self-citationFalhammar, H., Frisén, L., Hirschberg, A. L., Norrby, C., Almqvist, C., Nordenskjöld, A., & Nordenström, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2093 · Cited by 204
Congenital Adrenal Hyperplasia
Witchel, S. F. (2017) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2017.04.001 · Cited by 184
Engels, M., Span, P. N., van Herwaarden, A. E., Sweep, F. C. G. J., Stikkelbroeck, N. M. M. L., & Claahsen-van der Grinten, H. L. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00258 · Cited by 163
Nordenström, A., & Falhammar, H. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-0712 · Cited by 158
Clinical perspectives in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency
Bulsari, K., & Falhammar, H. (2016) · Endocrine · doi:10.1007/s12020-016-1189-x · Cited by 149
Falhammar, H., & Nordenström, A. (2015) · Endocrine · doi:10.1007/s12020-015-0656-0 · Cited by 127
Management challenges and therapeutic advances in congenital adrenal hyperplasia
Mallappa, A., & Merke, D. P. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00655-w · Cited by 113
Modified-Release Hydrocortisone in Congenital Adrenal Hyperplasia
Merke, D. P., Mallappa, A., Arlt, W., Brac de la Perriere, A., Lindén Hirschberg, A., Juul, A., Newell-Price, J., Perry, C. G., Prete, A., Rees, D. A., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab051 · Cited by 109
Self-citationTurcu, A. F., Mallappa, A., Elman, M. S., Avila, N. A., Marko, J., Rao, H., Tsodikov, A., Auchus, R. J., & Merke, D. P. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3989 · Cited by 107
Mazziotti, G., Formenti, A. M., Frara, S., Roca, E., Mortini, P., Berruti, A., & Giustina, A. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0154 · Cited by 96
Health status in 1040 adults with disorders of sex development (DSD): a European multicenter study
Falhammar, H., Claahsen-van der Grinten, H., Reisch, N., Slowikowska-Hilczer, J., Nordenström, A., Roehle, R., Bouvattier, C., Kreukels, B. P. C., Köhler, B., & _, _. (2018) · Endocrine Connections · doi:10.1530/ec-18-0031 · Cited by 76
Self-citationAl Alawi, A. M., Nordenström, A., & Falhammar, H. (2019) · Endocrine · doi:10.1007/s12020-018-01835-3 · Cited by 77
MANAGEMENT OF ENDOCRINE DISEASE: Gonadal dysfunction in congenital adrenal hyperplasia
Claahsen-van der Grinten, H. L., Stikkelbroeck, N., Falhammar, H., & Reisch, N. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-1093 · Cited by 72
Gonadal function in adult male patients with congenital adrenal hyperplasia
Engels, M., Gehrmann, K., Falhammar, H., Webb, E. A., Nordenström, A., Sweep, F. C., Span, P. N., van Herwaarden, A. E., Rohayem, J., Richter-Unruh, A., et al. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0862 · Cited by 69
Self-citationKing, T. F. J., Lee, M. C., Williamson, E. E. J., & Conway, G. S. (2016) · Clinical Endocrinology · doi:10.1111/cen.13001 · Cited by 66
Hirschberg, A. L., Gidlöf, S., Falhammar, H., Frisén, L., Almqvist, C., Nordenskjöld, A., & Nordenström, A. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa801 · Cited by 65
Dumić, M., Duspara, V., Grubić, Z., Oguić, S. K., Škrabić, V., & Kuŝec, V. (2017) · European Journal of Pediatrics · doi:10.1007/s00431-017-3008-7 · Cited by 64
Falhammar, H., Frisén, L., Norrby, C., Almqvist, C., Hirschberg, A. L., Nordenskjöld, A., & Nordenström, A. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01139 · Cited by 60
Bilateral Adrenalectomy in Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis
MacKay, D., Nordenström, A., & Falhammar, H. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00217 · Cited by 59
“Preoperative 163 6 102 192 (156) 146 (53) Postoperative 147 6 104 189 (147) 123 (62) Median 17OHP, nmol/L , 0.”
Bachelot, A., Grouthier, V., Courtillot, C., Dulon, J., & Touraine, P. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0888 · Cited by 57
Self-citationKocova, M., Janevska, V., & Anastasovska, V. (2018) · Endocrine Connections · doi:10.1530/ec-18-0097 · Cited by 51
Long-Term Outcomes of Congenital Adrenal Hyperplasia
Nordenström, A., Lajić, S., & Falhammar, H. (2022) · Endocrinology and Metabolism · doi:10.3803/enm.2022.1528 · Cited by 50
“If the lipid profile is at a disadvantage in patients with CAH is under debate [2,23,25-28,30,38] and in the previously mentioned meta-analysis similar lipid levels were reported in patients with CAH and matched controls [29].”
InfluentialDaae, E., Feragen, K. B., Nermoen, I., & Falhammar, H. (2018) · Endocrine · doi:10.1007/s12020-018-1723-0 · Cited by 45
Reisch, N. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0820-2085 · Cited by 36
“Inhibin B differs significantly in patients with and without TART and correlate with sperm concentrations [27].”
BackgroundResultInfluentialCorcioni, B., Renzulli, M., Marasco, G., Baronio, F., Gambineri, A., Ricciardi, D., Ortolano, R., Farina, D., Gaudiano, C., Cassio, A., et al. (2021) · Translational Andrology and Urology · doi:10.21037/tau-20-998 · Cited by 43
“Nevertheless, different series have reported that bilateralism was not present in all cases (17,20,28,34).”
InfluentialWitchel, S. F., & Topaloglu, A. K. (2019) · Yen and Jaffe's Reproductive Endocrinology · doi:10.1016/b978-0-323-47912-7.00017-2 · Cited by 35
Infertility and Reproductive Function in Patients with Congenital Adrenal Hyperplasia
Lekarev, O., Lin-Su, K., & Vogiatzi, M. G. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.07.009 · Cited by 38
Bachelot, A., Vialon, M., Baptiste, A., Tejedor, I., Elie, C., Polak, M., Touraine, P., & _, _. (2017) · Endocrine Connections · doi:10.1530/ec-17-0094 · Cited by 34
Self-citationPapadakis, G. E., Dumont, A., Bouligand, J., Chasseloup, F., Raggi, A., Catteau-Jonard, S., Boute‐Bénéjean, O., Pitteloud, N., Young, J., & Dewailly, D. (2020) · Human Reproduction · doi:10.1093/humrep/deaa020 · Cited by 38
Self-citationCardio-metabolic risk factors in youth with classical 21-hydroxylase deficiency
Ariyawatkul, K., Tepmongkol, S., Aroonparkmongkol, S., & Sahakitrungruang, T. (2017) · European Journal of Pediatrics · doi:10.1007/s00431-017-2875-2 · Cited by 36
Sarafoglou, K., Merke, D. P., Reisch, N., der Grinten, H. L. C., Falhammar, H., & Auchus, R. J. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad134 · Cited by 35
Pijnenburg-Kleizen, K. J., Thomas, C. M. G., Otten, B. J., Roeleveld, N., & der Grinten, H. L. C. (2019) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2019-0006 · Cited by 35
Improda, N., Barbieri, F., Ciccarelli, G. P., Capalbo, D., & Salerno, M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00212 · Cited by 34
Kim, J. H., Choi, S., Lee, Y. A., Lee, J., & Kim, S. G. (2022) · Endocrinology and Metabolism · doi:10.3803/enm.2021.1328 · Cited by 33
“more, other studies have reported similar risks for diabetes mellitus, hypertension, and dyslipidemia between CAH and control groups [6,12,19].”
ResultLong‐term health consequences of congenital adrenal hyperplasia
Pofi, R., Ji, X., Krone, N. P., & Tomlinson, J. (2023) · Clinical Endocrinology · doi:10.1111/cen.14967 · Cited by 30
“…profile is therefore suppressed or normal gonadotropins with testosterone levels within the lower normal range, but low inhibin B levels, 22,35 which can serve as an additional marker for Sertoli cell function alongside FSH. 27,35 In the attempt to distinguish testosterone of adrenal or…”
InfluentialRussian clinical practice guidelines «congenital adrenal hyperplasia»
Mokrysheva, N. G., Mel'nichenko, G. A., Adamyan, L. V., Troshina, E. A., Молашенко, Н. В., Игоревна, С. А., Uvarova, E. V., Esayan, E. R. M., Andreeva, E. N., Ужегова, Ж. А., et al. (2021) · Obesity and metabolism · doi:10.14341/omet12787 · Cited by 30
Metabolic syndrome and cardiovascular morbidity in patients with congenital adrenal hyperplasia
Barbot, M., Mazzeo, P., Lazzara, M., Ceccato, F., & Scaroni, C. M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.934675 · Cited by 28
“Contrastingly, some studies showed no increases in associated hypertension, probably related to both GC and MC undertreatment, as supported by the marked elevation in ACTH and plasmatic renin levels found inmost of the patients included (38).”
BackgroundResultDonadille, B., Houang, M., Netchine, I., Siffroi, J., & Christin‐Maître, S. (2018) · Endocrine Connections · doi:10.1530/ec-17-0306 · Cited by 28
Cardiometabolic Aspects of Congenital Adrenal Hyperplasia
Krysiak, R. G., der Grinten, H. L. C., Reisch, N., Touraine, P. A., & Falhammar, H. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae026 · Cited by 26
Self-citationLajić, S., Karlsson, L., Zetterström, R. H., Falhammar, H., & Nordenström, A. (2020) · International Journal of Neonatal Screening · doi:10.3390/ijns6030068 · Cited by 25
“Fertility in males with CAH is impaired [26,27], mainly due to hyper- or hypogonadotropic hypogonadism and testicular adrenal rest tumors (TARTs) [28].”
BackgroundKocova, M., Anastasovska, V., & Falhammar, H. (2020) · Endocrine · doi:10.1007/s12020-020-02323-3 · Cited by 24
Neonatal mass screening for 21-hydroxylase deficiency
Tajima, T., & Fukushi, M. (2016) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.25.1 · Cited by 25
Chaudhari, M., Johnson, E. K., Dajusta, D. G., & Nahata, L. (2017) · Journal of Pediatric Urology · doi:10.1016/j.jpurol.2017.11.011 · Cited by 24
Guo, X., Zhang, Y., Yu, Y., Zhang, L., Ullah, K., Ji, M., Jin, B., & Shu, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.982953 · Cited by 23
“The main cause of male infertility in CAH is testicular adrenal rest tumors (TARTs) (2, 3), which are benign, bilateral tumors in rete testis developed under the trophic effects of chronic adrenocorticotropic hormone (ACTH) elevation, compressing the seminiferous tubules (4).”
BackgroundBreil, T., Yakovenko, V., Inta, I. M., Choukair, D., Klose, D., Mittnacht, J., Schulze, E., Alrajab, A., Grulich‐Henn, J., & Bettendorf, M. (2019) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2018-0298 · Cited by 22
Gusmano, C., Cannarella, R., Crafa, A., Barbagallo, F., Vignera, S. L., Condorelli, R. A., & Calogero, A. E. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01849-9 · Cited by 21
Tanaka, M., Enatsu, N., Chiba, K., & Fujisawa, M. (2018) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12068 · Cited by 20
Bachelot, A., Lapoirie, M., Dulon, J., Leban, M., Renard Penna, R., & Touraine, P. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-0787 · Cited by 19
Self-citationTesticular adrenal rest tumors – Epidemiology, diagnosis and treatment
de Jesus, L. E., de Oliveira, A. P. P., Porto, L. C., & Dekermacher, S. (2023) · Journal of Pediatric Urology · doi:10.1016/j.jpurol.2023.10.005 · Cited by 19
der Grinten, H. L. C., Adriaansen, B. P. H., & Falhammar, H. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae718 · Cited by 19
Management aspects of congenital adrenal hyperplasia during adolescence and transition to adult care
Balagamage, C., Arshad, A., Elhassan, Y., Said, W. B., Krone, R. E., Gleeson, H. K., & Idkowiak, J. (2023) · Clinical Endocrinology · doi:10.1111/cen.14992 · Cited by 19
“78 The dsd ‐ Life study assessed gonadal function in 121 adult CAH men (median age 28 years), and nearly half of them had abnormalities in the HPG axis 79 ; more detailed hormonal assessment in a subsample showed that reduced gonadotropin concentrations were associated with lower testosterone and,…”
Choi, J., & Yoo, H. (2017) · Korean Journal of Pediatrics · doi:10.3345/kjp.2017.60.2.31 · Cited by 17
Early central blood pressure elevation in adult patients with 21-hydroxylase deficiency
Rosenbaum, D., Gallo, A., Lethielleux, G., Bruckert, E., Levy, B. I., Tanguy, M. L., Dulon, J., Dahmoune, N., Salem, J. E., Bittar, R., et al. (2019) · Journal of Hypertension · doi:10.1097/hjh.0000000000001850 · Cited by 15
Self-citationClinical outcomes in 21-hydroxylase deficiency
Nordenström, A., Lajić, S., & Falhammar, H. (2021) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000625 · Cited by 15
Righi, B., Ali, S., Bryce, J., Tomlinson, J., Bonfig, W., Baronio, F., Costa, E. C., Guaragna‐Filho, G., T'Sjoen, G. G., Cools, M., et al. (2023) · Endocrine · doi:10.1007/s12020-023-03330-w · Cited by 15
Testicular Adrenal Rest Tumor (TART) in congenital adrenal hyperplasia
Özışık, H., Yürekli, B. Ş., Şimşir, İ. Y., Altun, İ., Soyaltın, U. E., Güler, E., Önay, H., Sarsık, B., & Saygılı, F. (2017) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2017.06.009 · Cited by 14
Prenatal and Pregnancy Management of Congenital Adrenal Hyperplasia
Nowotny, H. F., Tschaidse, L., Auer, M. K., & Reisch, N. (2024) · Clinical Endocrinology · doi:10.1111/cen.15131 · Cited by 14
“TART presence is linked to suboptimal sperm parameters in a significant percentage of patients [5, 8, 14], especially in men with larger TART [75].”
Charoensri, S., & Auchus, R. J. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad628 · Cited by 13
Fertility and pregnancy in adrenal insufficiency
Green, D., Dineen, R., O’Reilly, M., & Sherlock, M. (2023) · Endocrine Connections · doi:10.1530/ec-23-0088 · Cited by 13
“Several controlled studies of fertility in men with CAH report a lower child rate compared to an age-matched healthy population ( 92 , 93 , 94 ).”
ResultLim, S. G., Lee, Y. A., Jang, H. N., Kong, S. H., Ahn, C. H., Kim, S. W., Shin, C. H., & Kim, J. H. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.761258 · Cited by 13
Kamenický, P., Blanchard, A., Lamazière, A., Piedvache, C., Donadille, B., Duranteau, L., Bry, H., Gautier, J., Salenave, S., Raffin‐Sanson, M., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz005 · Cited by 11
Self-citationNoppe, G., de Rijke, Y. B., Koper, J. W., van Rossum, E. F. C., & van den Akker, E. L. T. (2016) · Clinical Endocrinology · doi:10.1111/cen.13078 · Cited by 11
Testicular tumors of adrenogenital syndrome: From physiopathology to therapy
Naouar, S., Braiek, S., & Kamel, R. E. (2017) · La Presse Médicale · doi:10.1016/j.lpm.2017.05.006 · Cited by 10
Foetal exposure to mitotane/Op'DDD: Post‐natal study of four children
Magkou, D., Cao, C. D., Bouvattier, C. M., Douillard, C., Marcellus, C. D., Cazabat, L., Gérard, M., Raffin‐Sanson, M., & Young, J. (2018) · Clinical Endocrinology · doi:10.1111/cen.13854 · Cited by 10
Self-citationBancos, I., Kim, H., Cheng, H. K.-H., Rodríguez-Lee, M., Coope, H., Cicero, S., Goldsmith, H., Lin, V. H., & Jeha, G. S. (2025) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2025.2450423 · Cited by 9
Mineralocorticoid replacement therapy in salt‐wasting congenital adrenal hyperplasia
Lang, K., Quinkler, M. O., & Kienitz, T. (2023) · Clinical Endocrinology · doi:10.1111/cen.14959 · Cited by 9
Bilateral Adrenal and Testicular Mass in a Patient with Congenital Adrenal Hyperplasia
Pişkinpaşa, H., Dogansen, S. C., Cabuk, F. K., Guzey, D., Sahbaz, N. A., Akdeniz, Y. S., & Mert, M. (2019) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2019.113 · Cited by 9
Bone Mineral Density in Patients With Congenital Adrenal Hyperplasia From Prepubertal to Adult Age
Stancampiano, M. R., Pitea, M., Maruca, K., Meroni, S. L. C., Bucolo, C., Russo, G., & Mora, S. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf123 · Cited by 8
Health problems of adolescent and adult patients with 21-hydroxylase deficiency
Tajima, T. (2018) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.27.203 · Cited by 8
Faniev, M. V., Шевченко, Н. П., & Kadyrov, Z. A. (2017) · Andrology and Genital Surgery · doi:10.17650/2070-9781-2017-18-3-44-53 · Cited by 8
Testicular Dysfunction in Systemic Diseases
Sartorius, G. A., & Handelsman, D. J. (2023) · Springer eBooks · doi:10.1007/978-3-031-31574-9_34 · Cited by 7
Sperm cryopreservation in young males with congenital adrenal hyperplasia (CAH)
Chougar, T., Laanani, M., Ferreux, L., Chalas, C., Wolf, J., Bertherat, J. Y., Bouvattier, C. M., Polak, M., Bachelot, A., Dulon, J., et al. (2022) · Clinical Endocrinology · doi:10.1111/cen.14792 · Cited by 6
“Half of all patients (n = 10) showed a normal sperm count or concentration, while 10% and 15% showed severe and moderate oligozoospermia, respectively, within the range previously reported.(2,3) Azoospermia was reported in 25% of the patients.”
BackgroundResultSelf-citationMittnacht, J., Choukair, D., Breil, T., Klose, D., Inta, I. M., & Bettendorf, M. (2020) · Clinical Endocrinology · doi:10.1111/cen.14287 · Cited by 5
Sarfati, J., Vatier, C., Keller, I., Guechot, J., Bellanné‐Chantelot, C., & Christin‐Maître, S. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00103 · Cited by 4
Ortolano, R., Cassio, A., Alqaisi, R. S., Candela, E., Natale, V. D., Assirelli, V., Bernardini, L., Bortolamedi, E., Cantarelli, E., Corcioni, B., et al. (2023) · Children · doi:10.3390/children10091457 · Cited by 4
Martin, P., Russmann, M. L. E., Mendeluk, G. R., Fierro, M. F., Marino, R. M., & Pardes, E. (2020) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2020.07.003 · Cited by 5
Fouques, C., Fatfouta, I., Hiéronimus, S., Sadoul, J., & Bongain, A. (2019) · Basic and Clinical Andrology · doi:10.1186/s12610-019-0084-8 · Cited by 4
“Patients with testicular stunting have more severe sperm abnormalities [1].”
BackgroundInfluentialAhn, C. H., Shim, J., Jang, H. N., Lee, Y. A., Lee, S., Choi, M. H., & Kim, J. H. (2023) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2023.106374 · Cited by 4
Auer, M. K., Büyükerzurmulu, D., Lottspeich, C., Bidlingmaier, M., Rieger, E., Nowotny, H. F., Tschaidse, L., Auchus, R. J., & Reisch, N. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae112 · Cited by 3
Carrière, C., Sarfati, C., Téjédor, I., Dulon, J., Chakhtoura, Z., Courtillot, C., & Bachelot, A. (2022) · Annales d Endocrinologie · doi:10.1016/j.ando.2022.04.007 · Cited by 3
Ferreux, L., Boumerdassi, Y., Dulioust, E., BERTAGNA, X. Y., Roucher‐Boulez, F., Bourdon, M., Thiounn, N., & Patrat, C. (2023) · Basic and Clinical Andrology · doi:10.1186/s12610-022-00176-6 · Cited by 3
Ahmad, J., Ahmad, A., & Hadid, L. (2023) · Medicine · doi:10.1097/md.0000000000036061 · Cited by 3
“[5] In another study conducted in London on 50 patients, the male patients with severe oligospermia (11 out of 23) were more likely to have a TART on ultrasound (81.8 %).”
BackgroundInfluentialPsychological Evaluation of Patients with Congenital Adrenal Hyperplasia (CAH)
Athanasiadis, L. (2021) · Springer eBooks · doi:10.1007/978-3-030-82591-1_10 · Cited by 3
Hypogonadism in Males with Congenital Adrenal Hyperplasia
Stikkelbroeck, N. M. M. L., & der Grinten, H. L. C. (2017) · Springer eBooks · doi:10.1007/978-3-319-53298-1_7 · Cited by 2
Current and future perspectives on clinical management of classic 21-hydroxylase deficiency
Yogi, A., & Kashimada, K. (2023) · Endocrine Journal · doi:10.1507/endocrj.ej23-0075 · Cited by 2
Weniger, M., Mattes, M., Grünewald, T. G. P., Köhler, K., Hübner, A., Beuschlein, F., & Reisch, N. (2024) · Hormone and Metabolic Research · doi:10.1055/a-2216-0269 · Cited by 2
Serum inhibin B values in infertile patients
Kadyrov, Z. A., Moskvichev, D. D., & Faniev, M. V. (2016) · Andrology and Genital Surgery · doi:10.17650/2070-9781-2016-17-1-23-27 · Cited by 2
López, J. A. G., & Catalán, M. I. G. (1998) · Revista de la Facultad de Derecho de la Universidad Complutense · Cited by 2
Anaforoğlu, İ. (2021) · Springer eBooks · doi:10.1007/978-3-030-82591-1_5 · Cited by 1
Ilboudo, A., Sagna, Y., Dubreuil, S., Touraine, P. A., & Courtillot, C. (2022) · Annales d Endocrinologie · doi:10.1016/j.ando.2022.02.003 · Cited by 1
Self-citationHypogonadismus, Infertilität und sexuelle Dysfunktion bei systemischen Erkrankungen
Sartorius, G. A., & Handelsman, D. J. (2023) · Springer Reference Medizin · doi:10.1007/978-3-662-61901-8_34 · Cited by 1
Gonadal changes in children and adolescents with congenital adrenal hyperplasia
Mahmoud, R. A. A., Abdelrahman, M. E., Mohamed, H. H., & Elsedfy, H. H. (2024) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2024-0417 · Cited by 1
Testicular adrenal rest tumors in Indonesian boys with congenital adrenal hyperplasia
Chandra, E., Utari, A., Adriaansen, B. P. H., Westra, D., Ningrum, F. H., Santoso, A. G., van Herwaarden, A. E., & der Grinten, H. L. C. (2025) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2025-0026 · Cited by 1
Hypogonadismus, Infertilität und sexuelle Dysfunktion bei systemischen Erkrankungen
Sartorius, G. A., & Handelsman, D. J. (2021) · Springer Reference Medizin · doi:10.1007/978-3-662-61904-9_34-1 · Cited by 1
Schuppe, H., Köhn, F., & Linn, T. (2023) · Springer Reference Medizin · doi:10.1007/978-3-662-63400-4_156 · Cited by 1
Delai, A. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2022.tde-06052022-161625 · Cited by 1
Чугунов, І., Ильин, А. В., Bogolyubov, S. V., Кузнецова, Э. С., Orlova, E., & Kareva, M. (2015) · Problems of Endocrinology · doi:10.14341/probl201561417-23
Long-term steroid hormone concentrations in healthy children, in obesity, and in disease
Noppe, G. (2016) · EUR Research Repository (Erasmus University Rotterdam)
Metadata
- Authors
- Bouvattier, C., Esterle, L., Renoult-Pierre, P., de la Perrière, A. B., Illouz, F., Kerlan, V., Pascal-Vigneron, V., Drui, D., Christin-Maitre, S., Galland, F., Brue, T., Reznik, Y., Schillo, F., Pinsard, D., Piguel, X., Chabrier, G., Decoudier, B., Emy, P., Tauveron, I., Raffin-Sanson, M.-L., Bertherat, J., Kuhn, J.-M., Caron, P., Cartigny, M., Chabre, O., Dewailly, D., Morel, Y., Touraine, P., Tardy-Guidollet, V., & Young, J.
- Affiliations
- Université Paris-Sud (FR)
- Corresponding author
- Bouvattier, Claire
- Young, Jacques
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-06
- Volume
- 100
- Issue
- 6
- Pages
- 2303-2313
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2022040813
- Cited by
- 116
- References
- 43
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 6 · 2023: 16 · 2022: 13 · 2021: 13 · 2020: 6 · 2019: 10 · 2018: 13 · 2017: 15 · 2016: 5 · 2015: 5
- FWCI
- 5.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Assistance Publique - Hôpitaux de Paris
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Keywords
- congenital adrenal hyperplasia, adult male, testicular function, fertility, azoospermia, oligozoospermia, testicular adrenal rest tumor, gonadotropin deficiency, inhibin B, follicle-stimulating hormone, ACTH, 17-hydroxyprogesterone, androstenedione, short stature, salt wasting, hormonal status
- MeSH terms
- Adolescent, Adrenal Hyperplasia, Congenital, Adrenal Rest Tumor, Adult, Aged, Data Collection, France, Humans, Hypothalamo-Hypophyseal System, Male, Middle Aged, Prognosis, Gonadal Steroid Hormones, Testicular Neoplasms, Testis, Ultrasonography, Gonadotrophs, Semen Analysis, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.